<code id='24C78D98CC'></code><style id='24C78D98CC'></style>
    • <acronym id='24C78D98CC'></acronym>
      <center id='24C78D98CC'><center id='24C78D98CC'><tfoot id='24C78D98CC'></tfoot></center><abbr id='24C78D98CC'><dir id='24C78D98CC'><tfoot id='24C78D98CC'></tfoot><noframes id='24C78D98CC'>

    • <optgroup id='24C78D98CC'><strike id='24C78D98CC'><sup id='24C78D98CC'></sup></strike><code id='24C78D98CC'></code></optgroup>
        1. <b id='24C78D98CC'><label id='24C78D98CC'><select id='24C78D98CC'><dt id='24C78D98CC'><span id='24C78D98CC'></span></dt></select></label></b><u id='24C78D98CC'></u>
          <i id='24C78D98CC'><strike id='24C78D98CC'><tt id='24C78D98CC'><pre id='24C78D98CC'></pre></tt></strike></i>

          hotspot

          hotspot

          author:comprehensive    Page View:68
          Adobe

          Pharmacists increasingly are being asked to make drugs in bulk for hospitals that are in short supply, and they’re even beginning to make chemotherapies. But some in the industry worry about the unintended consequences of overreliance.

          Hospitals’ reliance on pharmacist-made drugs, a practice called compounding, has risen in step with worsening drug shortages.

          advertisement

          When the American Society of Health-System Pharmacists surveyed its members this past summer, 59% said they increased purchases from compounders because of drug shortages.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          Medicare details structure of new drug price negotiation program
          Medicare details structure of new drug price negotiation program

          MedicareonFridayreleasednewdetailsabouthowitsnewdrugpricenegotiationprogramwillwork,justtwomonthsbef

          read more
          Medicare Advantage's lean provider networks lead CMS complaints
          Medicare Advantage's lean provider networks lead CMS complaints

          InruralareassuchasBishop,Calif.,elderlypatientsonMedicareAdvantageplanscan'tfindin-networkprovidersw

          read more
          Novavax promises a turnaround & Lilly roils the obesity market
          Novavax promises a turnaround & Lilly roils the obesity market

          SammyKimballforSTATCanNovavaxfinallygetitright?What’sa“triple-G”drug?AndisNovoNordisklosingground?We

          read more

          Ozempic cut risk of death in diabetes patients with chronic kidney disease

          SEBASTIENBOZON/AFPviaGettyImagesNovoNordisk’sOzempiccuttheriskofdeathinatrialofpatientswithtype2diab